Source: Pharmabiz

Nucleix: A. Menarini Diagnostics, Nucleix enter partnership for exclusive distribution of Bladder EpiCheck test in Europe

A Menarini Diagnostics, a company bringing advanced solutions to the in vitro diagnostic market, and Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier,

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Chris Hibberd's photo - Chairman & CEO of Nucleix

Chairman & CEO

Chris Hibberd

CEO Approval Rating

85/100

Read more